azides has been researched along with deoxycytidine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.83) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 5 (20.83) | 2.80 |
| Authors | Studies |
|---|---|
| Bjursell, G; Skoog, L; Söderman, G; Thelander, L | 1 |
| Doskocil, J | 1 |
| Eckstein, F; Hobbs, J; Thelander, L | 1 |
| Knolle, G | 1 |
| Komatsu, Y; Tanaka, K | 1 |
| Cho, MJ; Cory, JG; Kang, SH; Mitchell, BS; Sinhababu, AK; Thakker, DR | 1 |
| Benkestock, K; Cammack, N; Johansson, NG; Kaiser, AC; Kalayanov, G; Klumpp, K; Le Pogam, S; Leveque, VJ; Maag, H; Maltseva, T; Martin, JA; Najera, I; Rajyaguru, S; Smith, DB; Smith, M; Sund, C; Swallow, S; Winqvist, A; Zhou, XX | 1 |
| Cavallaro, G; Celia, C; Fresta, M; Giammona, G; Licciardi, M; Paolino, D | 1 |
| Chang, J; Fan, Q; Guo, X; Jiang, J; Liu, X; Pan, Z; Qi, W; Song, C; Wang, N; Wang, Q; Yu, X; Zhang, Y; Zheng, L | 1 |
| Bortvin, A; Greenberg, MM; Guan, L; van der Heijden, GW | 1 |
| An, H; Chang, J; Chen, L; Dong, L; Guo, X; Li, Y; Tao, L; Wang, Q; Yang, X; Yu, X; Zheng, L | 1 |
| Chang, J; Jiang, J; Sun, C; Wang, Q; Yang, Q; Yang, X; Zhang, Y; Zhao, J; Zheng, L; Zhou, Y | 1 |
| Chang, J; Gao, C; Gao, Z; Niu, Z; Qin, Z; Song, X; Wang, H; Wang, J; Wang, X | 1 |
| Aguilar, M; Awad, AM; McNary, J; Samuels, ER | 1 |
| Chang, JB; Chen, H; Cui, XQ; Dai, SX; Huang, JF; Liu, YJ; Luo, RH; Peng, YM; Wang, RR; Yang, QH; Zhang, XJ; Zheng, YT | 1 |
| Chang, JB; Ding, XX; Jiang, JH; Ma, F; Wang, CP; Wang, N; Wang, QD; Zhang, Y | 1 |
| Chang, J; Li, Z; Shi, J; Wang, R; Xie, Y; Yang, L | 1 |
| Chang, J; Huang, C; Jiang, J; Liu, B; Liu, Y; Peng, Y; Wang, N; Wang, Q; Zhang, Y | 1 |
| Chang, J; Jiang, J; Liu, B; Liu, Y; Ma, F; Peng, Y; Wang, Q; Wang, Y | 1 |
| Chai, J; Chang, J; Chen, J; Han, Z; Hou, J; Huang, Z; Jin, X; Li, E; Liang, L; Peng, Y; Qiao, Y; Song, C; Sun, L; Wang, JH; Wang, Q; Wu, M; Yu, W; Zhang, B; Zhang, D; Zhang, Y; Zhao, Q | 1 |
| Chang, J; Yu, B | 1 |
| Chang, JB; Che, Y; Cheng, Z; Cui, JJ; Jiang, JD; Li, K; Li, R; Li, SY; Li, YH; Liu, B; Liu, HQ; Liu, Y; Lu, SY; Ma, CX; Peng, XZ; Shao, FM; Sheng, N; Sun, PC; Wan, YH; Wang, C; Wang, CY; Wang, K; Wang, LL; Wang, Z; Yu, SS; Zhang, JL; Zhang, Q; Zhao, LM; Zhu, B | 1 |
| Deng, G; Li, D; Liu, Y; Shen, M | 1 |
| Gao, Y; Hu, Z; Luo, Z; Ma, Y | 1 |
24 other study(ies) available for azides and deoxycytidine
| Article | Year |
|---|---|
2'-Deoxy-2'-azidocytidine inhibits the initiation of polyoma DNA synthesis.
Topics: Azides; Cell Line; Chromosome Mapping; Cytidine; Deoxycytidine; DNA Replication; DNA Restriction Enzymes; DNA, Viral; Electrophoresis, Agar Gel; Microscopy, Electron; Molecular Weight; Polyomavirus; Virus Replication | 1977 |
The role of thiol groups in nucleoside transport.
Topics: Arsenates; Azides; Biological Transport, Active; Chloromercuribenzoates; Deoxycytidine; Deoxyribonucleosides; Dinitrophenols; Drug Resistance, Microbial; Escherichia coli; Ethylmaleimide; Guanosine; Iodoacetates; Kinetics; Ribonucleosides; Showdomycin; Sulfhydryl Reagents | 1976 |
The active site of ribonucleoside diphosphate reductase.
Topics: Azides; Binding Sites; Deoxycytidine; Deoxyuridine; Molecular Weight; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases | 1977 |
[Antiviral therapy of HIV-infection].
Topics: Antiviral Agents; Azides; Deoxycytidine; HIV Seropositivity; Humans; Interferons | 1988 |
Deoxycytidine uptake by isolated membrane vesicles from Escherichia coli K 12.
Topics: Ascorbic Acid; Azides; Biological Transport; Carbon Isotopes; Cell Fractionation; Cell Membrane; Chloromercuribenzoates; Deoxycytidine; Deoxyribonucleosides; Electron Transport; Escherichia coli; Iodoacetates; Lactates; Mutation; NAD; Nucleosides; Organoids; Proline; Succinates; Thymidine; Time Factors; Uridine | 1973 |
Cellular delivery of nucleoside diphosphates: a prodrug approach.
Topics: Animals; Antineoplastic Agents; Azides; Cell Division; Cell Line; CHO Cells; Cricetinae; Cytidine Diphosphate; Deoxycytidine; Deoxycytidine Kinase; Deoxyuracil Nucleotides; Deoxyuridine; Dideoxynucleotides; Hydrolysis; Permeability; Phosphorylation; Prodrugs; Ribonucleotide Reductases; Tumor Cells, Cultured; Uridine Monophosphate | 1997 |
The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4'-azidocytidine against hepatitis C virus replication: the discovery of 4'-azido-2'-deoxy-2'-fluorocytidine and 4'-azido-2'-dideoxy-2',2'-difluorocytidine.
Topics: Antiviral Agents; Azides; Cell Line, Tumor; Deoxycytidine; Drug Design; Hepacivirus; Humans; Virus Replication | 2009 |
Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs.
Topics: Antineoplastic Agents; Azides; Biocompatible Materials; Cell Line, Tumor; Deoxycytidine; Drug Carriers; Drug Delivery Systems; Folic Acid; Gemcitabine; Humans; Materials Testing; Microscopy, Confocal; Molecular Structure; Peptides; Polymers; Tissue Distribution | 2010 |
FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells.
Topics: Animals; Antineoplastic Agents; Azides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Humans; Inhibitory Concentration 50; Mice | 2011 |
Intracellular detection of cytosine incorporation in genomic DNA by using 5-ethynyl-2'-deoxycytidine.
Topics: Alkynes; Animals; Azides; Base Sequence; Copper; Cytosine; Deoxycytidine; Deoxycytosine Nucleotides; DNA; DNA Repair; DNA Replication; DNA-Directed DNA Polymerase; Female; Fluorescent Dyes; Genome; Intracellular Space; Male; Mice; Molecular Probe Techniques; Spermatozoa; Zygote | 2011 |
Antiviral activity of FNC, 2'-deoxy-2'-β-fluoro-4'-azidocytidine, against human and duck HBV replication.
Topics: Animals; Antiviral Agents; Azides; Cell Line, Tumor; Deoxycytidine; Ducks; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Liver; Virus Replication | 2012 |
Novel nucleoside analogue FNC is effective against both wild-type and lamivudine-resistant HBV clinical isolates.
Topics: Adult; Antiviral Agents; Azides; Cell Line; Cell Survival; Deoxycytidine; Drug Resistance, Viral; Genotype; Hep G2 Cells; Hepatitis B virus; Humans; Male; Virus Replication | 2012 |
The pyrimidine analog FNC inhibits cell proliferation and viral protein synthesis in HTLV‑1‑infected cells.
Topics: Azides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; G1 Phase Cell Cycle Checkpoints; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Protein Biosynthesis; Pyrimidines; S Phase; Viral Proteins | 2013 |
Effective synthesis of 3'-deoxy-3'-azido nucleosides for antiviral and antisense ribonucleic guanidine (RNG) applications.
Topics: Azides; Deoxycytidine; Deoxyuridine; Nucleic Acid Conformation; Oligodeoxyribonucleotides; RNA, Antisense | 2013 |
Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro.
Topics: Anti-HIV Agents; Azides; Cell Line; Deoxycytidine; Drug Resistance, Viral; Genotype; HIV; HIV Reverse Transcriptase; Humans; Lamivudine; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Protein Binding; Reverse Transcriptase Inhibitors; Virus Replication | 2014 |
FNC, a novel nucleoside analogue, blocks invasion of aggressive non-Hodgkin lymphoma cell lines via inhibition of the Wnt/β-catenin signaling pathway.
Topics: Antineoplastic Agents; Azides; beta Catenin; Cadherins; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxycytidine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lymphoma, Non-Hodgkin; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; RNA, Messenger; Vascular Endothelial Growth Factor A; Wnt Proteins; Wnt Signaling Pathway | 2014 |
Investigation of the binding between pepsin and nucleoside analogs by spectroscopy and molecular simulation.
Topics: Azides; Deoxycytidine; Energy Transfer; Molecular Docking Simulation; Pepsin A; Protein Binding; Protein Conformation; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Temperature | 2015 |
Intestinal absorption mechanisms of 2'-deoxy-2'-β-fluoro-4'-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Azides; Caco-2 Cells; Deoxycytidine; Humans; Intestinal Absorption; Intestine, Small; Male; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Rats, Sprague-Dawley | 2017 |
Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions.
Topics: Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Azides; Biological Transport; Caco-2 Cells; Deoxycytidine; Drug Interactions; Humans; Intestinal Absorption; Male; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Rats; Rats, Sprague-Dawley; Up-Regulation | 2018 |
Mechanistic Insight into Antiretroviral Potency of 2'-Deoxy-2'-β-fluoro-4'-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention.
Topics: Animals; Anti-HIV Agents; Azides; Deoxycytidine; HIV Infections; HIV-1; Humans; Lamivudine; Macaca mulatta; Models, Molecular; Reverse Transcriptase Inhibitors; Ubiquitination | 2020 |
Azvudine (FNC): a promising clinical candidate for COVID-19 treatment.
Topics: Azides; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Deoxycytidine; Humans; Pandemics; Pilot Projects; Pneumonia, Viral; SARS-CoV-2; Tablets | 2020 |
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antiviral Agents; Azides; Coronavirus OC43, Human; COVID-19 Drug Treatment; Deoxycytidine; Female; Humans; Male; Middle Aged; Rats; SARS-CoV-2; Thymus Gland | 2021 |
Evaluate clinical effectiveness of Azvudine with data rather than speculation.
Topics: Azides; Deoxycytidine; Humans; Treatment Outcome | 2023 |
Real-world effectiveness of azvudine: Elixir or equivocal answer?
Topics: Azides; Deoxycytidine; Humans | 2023 |